FIT Biotech Oy: FIT Biotech webcasts the company half-year financial report on September 6th 2018, at 10.00 AM.

FIT Biotech Oy                                                                                              

Press Release July 3^rd 2018, 08.30 EET

FIT Biotech webcasts the company half-year financial report on September 6^th 2018, at 10.00 AM.

FIT Biotech’s half-year financial report will be webcasted on September 6^th 2018, at 10.00 AM.

The webcast can be followed in the following link: https://www.inderes.fi/videot/fit-biotech-webcast-2018-puolivuosikatsaus-692018-1000-alkaen

Additional information:
CEO Erkki Pekkarinen
Phone +358 44 027 0080
email: erkki.pekkarinen@fitbiotech.com

About FIT Biotech
FIT Biotech Oy is a biotechnology company established in 1995. The company develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy.

FIT Biotech applies GTU® technology in its drug development programmes. Application areas include cancer (gene therapy) and infectious diseases.

FIT Biotech shares are listed on the First North Finland marketplace maintained by Nasdaq Helsinki Oy.

DISTRIBUTION:
Principal media
www.fitbiotech.fi